NEW YORK, March 18 - Lion Bioscience on Monday said it has hired Martin Hollenhorst as chief financial officer to replace Klaus Sprockamp, who perished in the Sept. 11 attacks on the World Trade Center here.

Hollenhorst, 43, will "assume overall responsibility for the finance, controlling, and accounting divisions" of Lion as of April 1, the company said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In a survey, about half of Canadian government scientists say they still feel as though they cannot speak freely, ScienceInsider reports.

The Atlantic reports that biohacker Josiah Zayner regrets injecting himself with the CRISPR gene-editing tool on stage.

Clinicians in China are moving ahead with a number of CRISPR trials, NPR reports, as the US embarks on its first.

In Nature this week: genomic approaches applied to study Neolithic and Bronze Age Europeans, and more.